Sublingual vaccination with influenza virus protects mice against lethal viral infection
- Authors
- Song, Joo-Hye; Nguyen, Huan H.; Cuburu, Nicolas; Horimoto, Taisuke; Ko, Sung-Youl; Park, Se-Ho; Czerkinsky, Cecil; Kweon, Mi-Na
- Issue Date
- 5-2월-2008
- Publisher
- NATL ACAD SCIENCES
- Keywords
- intranasal; mucosal adjuvant; mucosal immunity; redirection; secretory IgA
- Citation
- PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, v.105, no.5, pp.1644 - 1649
- Indexed
- SCIE
SCOPUS
- Journal Title
- PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Volume
- 105
- Number
- 5
- Start Page
- 1644
- End Page
- 1649
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/124090
- DOI
- 10.1073/pnas.0708684105
- ISSN
- 0027-8424
- Abstract
- We assessed whether the sublingual (s.l.) route would be an effective means of delivering vaccines against influenza virus in mice by using either formalin-inactivated or live influenza A/PR/8 virus (H1N1). Sublingual administration of inactivated influenza virus given on two occasions induced both systemic and mucosal antibody responses and conferred protection against a lethal intranasal (i.n.) challenge with influenza virus. Coadministration of a mucosal adjuvant (mCTA-LTB) enhanced these responses and resulted in complete protection against respiratory viral challenge. In addition, s.l. administration of formalin-inactivated A/PR/8 plus mCTA-LTB induced systemic expansion of IFN-gamma-secreting T cells and virus-specific cytotoxic T lymphocyte responses. Importantly, a single s.l. administration of live A/PR/8 virus was not pathogenic and induced protection mediated by both acquired and innate immunity. Moreover, s.l. administration of live A/PR/8 virus conferred heterosubtypic protection against respiratory challenge with H3N2 virus. Unlike the i.n. route, the A/PR/8 virus, whether live or inactivated, did not migrate to or replicate in the CNS after s.l. administration. Based on these promising findings, we propose that the s.l. mucosal route offers an attractive alternative to mucosal routes for administering influenza vaccines.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Graduate School > Department of Life Sciences > 1. Journal Articles
- Graduate School > Department of Biotechnology > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.